Early Diagnosis of Lung Cancer: The Urgent Need of a Clinical Test
Open accessAbstract
Globally, lung cancer continues to be the leading cause of cancer death in men and women [...]
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Without definitive tests, healthcare providers often depend on clinical judgment and broader testing approaches, sometimes resulting in diagnostic errors.
“Without definitive tests, healthcare providers often depend on clinical judgment and broader testing approaches, sometimes resulting in diagnostic errors.”
From Toward Safer Diagnoses: A SEIPS-Based Narrative Review of Diagnostic Errors (2026) · cites this paper as [186]
In the main text of “Early Diagnosis of Lung Cancer: The Urgent Need of a Clinical Test” (page not provided), the authors say adequate screening methods are lacking and describe false positives and overdiagnosis with low-dose CT. The paper does not say that providers often rely on clinical judgment or broader testing approaches, so that part of the attributed claim is unsupported. (LLM, conf=0.82)
Experimental — accuracy not yet measuredThere is a lack of appropriate or specific diagnostic tests for certain conditions or diseases, especially in their early stages.
“First, there is a lack of appropriate or specific diagnostic tests for certain conditions or diseases, especially in their early stages [185,186,187].”
From Toward Safer Diagnoses: A SEIPS-Based Narrative Review of Diagnostic Errors (2026) · cites this paper as [186]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
No citation lists for this paper
No citation lists for this paper yet — checked again daily.
References 16 · Cited by 7
Research works printed but not linked: 14
- [1]Barta J.A. Powell C.A. Wisnivesky J.P. Global Epidemiology of Lung Cancer Ann. Glob. Health 2019 85 8 10.5334/aogh.2419 30741509 PMC6724220 · DOI
- [4]Nooreldeen R. Bach H. Current and Future Development in Lung Cancer Diagnosis Int. J. Mol. Sci. 2021 22 8661 10.3390/ijms22168661 34445366 PMC8395394 · DOI
- [6]Ladabaum U. Dominitz J.A. Kahi C. Schoen R.E. Strategies for Colorectal Cancer Screening Gastroenterology 2020 158 418 432 10.1053/j.gastro.2019.06.043 31394083 · DOI · Paper page
- [7]Carlsson S.V. Vickers A.J. Screening for Prostate Cancer Med. Clin. N. Am. 2020 104 1051 1062 10.1016/j.mcna.2020.08.007 33099450 PMC8287565 · DOI
- [8]Wood D.E. Kazerooni E.A. Aberle D. Berman A. Brown L.M. Eapen G.A. Ettinger D.S. Ferguson J.S. Hou L. Kadaria D. Lung Cancer Screening, Version 1.2022 Featured Updates to the NCCN Guidelines J. Natl. Compr. Cancer Netw. 2022 20 754 764 10.6004/jnccn.2022.0036 35830884 · DOI
- [9]Fu F. Zhou Y. Zhang Y. Chen H. Lung cancer screening strategy for non-high-risk individuals: A narrative review Transl. Lung Cancer Res. 2021 10 452 461 10.21037/tlcr-20-943 33569326 PMC7867778 · DOI
- [10]Chang H.T. Wang P.H. Chen W.F. Lin C.J. Risk Assessment of Early Lung Cancer with LDCT and Health Examinations Int. J. Environ. Res. Public Health 2022 19 4633 10.3390/ijerph19084633 35457500 PMC9033135 · DOI
- [11]Lemjabbar-Alaoui H. Hassan O.U. Yang Y.-W. Buchanan P. Lung cancer: Biology and treatment options Biochim. Biophys. Acta (BBA)-Rev. Cancer 2015 1856 189 210 10.1016/j.bbcan.2015.08.002 26297204 PMC4663145 · DOI
- [12]Menyhárt O. Győrffy B. Multi-omics approaches in cancer research with applications in tumor subtyping, prognosis, and diagnosis Comput. Struct. Biotechnol. J. 2021 19 949 960 10.1016/j.csbj.2021.01.009 33613862 PMC7868685 · DOI
- [13]Chakraborty S. Hosen I. Ahmed M. Shekhar H.U. Onco-Multi-OMICS Approach: A New Frontier in Cancer Research BioMed Res. Int. 2018 2018 9836256 10.1155/2018/9836256 30402498 PMC6192166 · DOI
- [15]Seijo L.M. Peled N. Ajona D. Boeri M. Field J.K. Sozzi G. Pio R. Zulueta J.J. Spira A. Massion P.P. Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges J. Thorac. Oncol. 2019 14 343 357 10.1016/j.jtho.2018.11.023 30529598 PMC6494979 · DOI
- [16]Bodein A. Scott-Boyer M.-P. Perin O. Cao K.-A.L. Droit A. Interpretation of network-based integration from multi-omics longitudinal data Nucleic Acids Res. 2021 50 e27 10.1093/nar/gkab1200 34883510 PMC8934642 · DOI
- [17]Yu X.T. Zeng T. Integrative analysis of omics big data Methods Mol. Biol. 2018 1754 109 135 29536440
- [18]Lv J. Li J. Liu Y. Zhang H. Luo X. Ren M. Gao Y. Ma Y. Liang S. Yang Y. Artificial Intelligence-Aided Diagnosis Software to Identify Highly Suspicious Pulmonary Nodules Front. Oncol. 2022 11 749219 10.3389/fonc.2021.749219 35242696 PMC8886673 · DOI
- Authors
- Gasparri, R., Guaglio, A., & Spaggiari, L.
- Affiliations
- European Institute of Oncology (IT)
- University of Milan (IT)
- Corresponding author
- Gasparri, Roberto
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2022-07-28
- Volume
- 11
- Issue
- 15
- Pages
- 4398
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC9368855
- OpenAlex
- W4288442929
- Cited by
- 7
- References
- 16
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 3 · 2022: 1
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Lung Cancer Research Studies
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- lung cancer, early diagnosis, clinical diagnostic tests, cancer screening, cancer mortality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
